tiprankstipranks
Trending News
More News >
Promising Potential of Anavex Life Sciences’ Blarcamesine in Alzheimer’s Treatment Reinforces Buy Rating
PremiumRatingsPromising Potential of Anavex Life Sciences’ Blarcamesine in Alzheimer’s Treatment Reinforces Buy Rating
30d ago
Anavex announces results from Phase IIb/III open-label extension trial
Premium
The Fly
Anavex announces results from Phase IIb/III open-label extension trial
1M ago
Buy Rating for Anavex: Capitalizing on European Market Opportunities Amid Eli Lilly’s Setback
Premium
Ratings
Buy Rating for Anavex: Capitalizing on European Market Opportunities Amid Eli Lilly’s Setback
1M ago
Anavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus
PremiumCompany AnnouncementsAnavex Life Sciences Reports Higher Quarterly Loss Amid R&D Focus
3M ago
Anavex reports Q1 EPS (14c) vs. (11c) last year
Premium
The Fly
Anavex reports Q1 EPS (14c) vs. (11c) last year
3M ago
Anavex sees cash runway of four years
Premium
The Fly
Anavex sees cash runway of four years
3M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
Anavex announces peer-reviewed publication Phase IIb/III data on blarcamesine
Premium
The Fly
Anavex announces peer-reviewed publication Phase IIb/III data on blarcamesine
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100